NORD on the Need for More Collaboration to Drive Progress for Rare Disease Patients

Many biopharmaceutical companies are actively engaged in the research and development of therapies to treat rare disease, despite challenges such as much smaller patient populations than more common...
Read More
#RarePOV Conversation Generates Strong Enthusiasm for Rare Disease Day on February 28th

In last week’s #RarePOV tweetchat, leading rare disease advocacy organizations and individual patient advocates came together to share resources and plans for the upcoming international Rare Disease...
Read More